Skip to content

Integrating Conservative Kidney Management Options and Advance Care Planning Into a Pre-Dialysis Educational Program

Integrating Conservative Kidney Management Options and Advance Care Planning Into a Pre-Dialysis Educational Program

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03229811
Enrollment
4
Registered
2017-07-26
Start date
2021-10-24
Completion date
2021-12-14
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Care Planning, Chronic Kidney Diseases, Conservative Kidney Management

Brief summary

The goals of this work will be to evaluate the preliminary efficacy of a comprehensive pre-dialysis education program on increased knowledge of conservative kidney management and advance care planning among patients with advanced CKD.

Detailed description

This intervention will be randomized among patients with advanced chronic kidney disease.

Interventions

OTHERESRD education + conservative kidney management and ACP education

Targeted conservative kidney management and advance care planning education delivered in person by trained healthcare providers

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Intervention model description

Comprehensive pre-dialysis program incorporating conservative and advance care planning education

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stage 4 or 5 CKD (defined by the CKD-EPI estimation of GFR \< 30 ml/min/1.73m2) * Age 65 years or greater or frail * self-reported Black or White race

Exclusion criteria

* History of dementia * History of legal blindness * Listed for kidney transplantation

Design outcomes

Primary

MeasureTime frameDescription
Knowledge of Conservative Kidney Management and Advance Care Planning (Pre-intervention)Pre-intervention and Day 1 post-interventionKnowledge of conservative kidney management and advance care planning pre-intervention (mean score) Total score ranges from 0 to 9, where 9 represents having the most knowledge about conservative kidney management and advance care planning
Knowledge of Conservative Kidney Management and Advance Care Planning (Post-intervention)Immediate post-interventionKnowledge of conservative kidney management and advance care planning post-intervention (mean score) Total score ranges from 0 to 9, where 9 represents having the most knowledge about conservative kidney management and advance care planning

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard Pre-dialysis Education
Standard pre-dialysis options education including hemodialysis, peritoneal dialysis, and kidney transplantation
0
ESRD Education + ACP
Standard ESRD education + conservative kidney management and advance care planning education ESRD education + conservative kidney management and ACP education: Targeted conservative kidney management and advance care planning education delivered in person by trained healthcare providers
4
Total4

Baseline characteristics

CharacteristicESRD Education + ACPTotalStandard Pre-dialysis Education
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants4 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous76 years
STANDARD_DEVIATION 6.06
76 years
STANDARD_DEVIATION 6.06
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants
Race (NIH/OMB)
Black or African American
2 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants
Race (NIH/OMB)
White
2 Participants2 Participants
Region of Enrollment
United States
4 participants4 participants
Sex: Female, Male
Female
2 Participants2 Participants0 Participants
Sex: Female, Male
Male
2 Participants2 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 4
serious
Total, serious adverse events
0 / 00 / 4

Outcome results

Primary

Knowledge of Conservative Kidney Management and Advance Care Planning (Post-intervention)

Knowledge of conservative kidney management and advance care planning post-intervention (mean score) Total score ranges from 0 to 9, where 9 represents having the most knowledge about conservative kidney management and advance care planning

Time frame: Immediate post-intervention

Population: No participants were randomized to standard education. One enrolled participant did not complete the post-knowledge questionnaire

ArmMeasureValue (MEAN)Dispersion
ESRD Education + ACPKnowledge of Conservative Kidney Management and Advance Care Planning (Post-intervention)8.67 score on a scaleStandard Deviation 0.58
Primary

Knowledge of Conservative Kidney Management and Advance Care Planning (Pre-intervention)

Knowledge of conservative kidney management and advance care planning pre-intervention (mean score) Total score ranges from 0 to 9, where 9 represents having the most knowledge about conservative kidney management and advance care planning

Time frame: Pre-intervention and Day 1 post-intervention

Population: No participants were randomized to standard education

ArmMeasureValue (MEAN)Dispersion
ESRD Education + ACPKnowledge of Conservative Kidney Management and Advance Care Planning (Pre-intervention)5.75 score on a scaleStandard Deviation 3.6

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026